Genetics

Genetics is the study of genes and heredity. Heredity is the passing of genetic information and traits (such as eye color and an increased chance of getting a certain disease) from parents to offspring.

How Do Genetic Mutations Cause Disease?

Mutations in genes can lead to genetic disorders, impacting health. Understand the types, causes, and implications of genetic mutations and disease.

START and STOP Codons

Genotype Versus Phenotype

Applications of the Expanded Genetic Code

Genetic Regulation of Fingers and Toes Development

Genetics of Inflammatory Bowel Disease (IBD)

Genetic Change

The Importance of Genetic Counseling In Healthcare And Medicine

Genetic Inheritance

Genetic Risk Associated with Social Anxiety

Von Recklinghausen Disease Expressivity

What is Genetic Anticipation?

See more featured articles »

The Role of Alternative Splicing in Disease

History of Genetics

What is Cytogenetics?

What is the Expanded Genetic Code?

Genetics and Gene Expression

Genetics Research and Technology

Latest Genetics News and Research

Toxoplasma remodels host cell surfaces to trigger invasion

At first, cholesterol and glycosylation seemed like two separate leads. As the researchers followed them, however, the pathways converged.

25 Sep 2026

EGFR co-targeting and nanotechnology offer new triple-negative breast cancer therapies

Triple-negative breast cancer (TNBC) remains one of the most challenging forms of breast cancer to treat because it lacks the estrogen, progesterone and HER2 receptors that enable targeted treatment in other breast cancer subtypes.

24 Sep 2026

Protein modification network plays vital role in cancer development

A review published in Genes & Diseases highlights the complex interplay between protein arginine methylation and ubiquitination, two forms of protein modification that can profoundly influence cancer development, progression and treatment response.

24 Sep 2026

Review highlights how altered metabolism drives kidney cancer growth

Clear cell renal cell carcinoma (ccRCC), the most common subtype of kidney cancer, is increasingly understood as a malignancy shaped by profound changes in cellular metabolism.

24 Sep 2026

PsychAD studies map molecular mechanisms across major brain disorders

Research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative launched in 2019 with support from the National Institute on Aging (NIA), is featured in a landmark collection of nine papers published across the Nature family of journals that maps the molecular mechanisms underlying Alzheimer's disease, Parkinson's disease, schizophrenia, and other brain disorders.

23 Sep 2026

A child's gut microbiome may offer early clues to type 1 diabetes risk

Researchers tracking 887 children at high genetic risk of type 1 diabetes identified three distinct patterns of gut microbiome maturation during early childhood. One pattern was associated with substantially higher risk of islet autoantibody seroconversion or type 1 diabetes, while host genetic background altered the risk associated with another pattern.

23 Sep 2026

New 3D lipid atlas maps the chemistry of mouse brains

The brain is often described in terms of cells and wiring. However, much of it is made of lipids that form the membranes of neurons, wrap nerve fibers with myelin, and help brain cells send and receive signals.

23 Sep 2026

BD² awards millions to study bipolar disorder mood changes

Breakthrough Discoveries for thriving with Bipolar Disorder (BD²) today announced its fourth round of Discovery Research grants, totaling more than $13 million, focused on the biological mechanisms of intense mood changes, a hallmark of bipolar disorder.

22 Sep 2026

Brain Health WA resource aims to reduce dementia risk

With Western Australia projected to record the nation's fastest growth in dementia cases, a new Curtin University-led resource aims to help people protect their brain health and reduce their risk.

22 Sep 2026

Galimedix establishes Scientific Advisory Board for Alzheimer’s disease to guide development of novel oral drug candidate, GAL-101

Galimedix Therapeutics, Inc., a Phase 2 clinical-stage biotechnology company developing novel oral and topical neuroprotective therapies with the potential to revolutionize the treatment of serious brain and eye diseases, today announced the establishment of a dedicated Alzheimer's Disease Scientific Advisory Board (SAB).

From Galimedix Therapeutics, INC. 22 Sep 2026

Children who ate healthier plant foods had slightly lower blood pressure later

Researchers followed 3,990 Dutch children for an average of 1.6 years and found that higher healthful plant-based diet scores were associated with modestly lower blood pressure and total cholesterol. Children with higher unhealthful plant-based diet scores had lower estimated food costs and distinct metabolite profiles, while healthful scores showed no clear cost association.

22 Sep 2026

Roundworm study uncovers cellular effects of kidney disease mutation

A microscopic worm that has no kidneys is helping Rutgers scientists understand a genetic change suspected of causing a serious inherited kidney disease.

21 Sep 2026

Researchers identify a rare genetic change linked to neurodevelopmental disorder

Research led by Texas Children's Duncan Neurological Research Institute (Duncan NRI) and Baylor College of Medicine identified a rare genetic change that appears to cause a newly recognized neurodevelopmental disorder.

21 Sep 2026

Stalled gut microbiome development triples risk for type 1 diabetes in children

Type 1 diabetes affects more than 9 million people worldwide, including 1.8 million children and adolescents.

21 Sep 2026

Sex differences in infant attention are present hours after birth

Cambridge scientists have shown that girls and boys show differences in what they pay attention to, even at birth.

21 Sep 2026

High adolescent BMI linked to faster biological aging in adulthood

A study by the Faculty of Sport and Health Sciences at the University of Jyväskylä, Finland, found that a high adolescent body mass index (BMI) may be linked to accelerated biological aging in adulthood.

21 Sep 2026

Largest neuroimaging study of bulimia nervosa finds structural brain differences linked to diagnosis and binge-eating severity

Researchers at the Icahn School of Medicine at Mount Sinai found that individuals with bulimia nervosa have structural differences in brain regions involved in reward and motivation, as well as social and sensory processing, and that more frequent binge eating is associated with more widespread differences in brain structure, according to research published today in JAMA Psychiatry.

18 Sep 2026

New study defines rare TCF7L2-related neurodevelopmental disorder

Researchers have completed the largest study to date of TCF7L2-related neurodevelopmental disorder (TRND), a rare genetic condition caused by changes in the TCF7L2 gene, which plays an important role in brain development.

18 Sep 2026

Sex-specific biological clocks reveal how aging differs across the body in women and men

Researchers developed 38 sex-specific biological aging clocks across 15 organ systems, finding differences between females and males in genetic architecture, molecular signatures, disease associations, and mortality patterns. Brain aging clocks were linked to progression from mild cognitive impairment to Alzheimer’s disease in both sexes and to sex-dependent cognitive trajectories among solanezumab-treated A4 participants, while the authors stressed that sex-pooled and sex-interaction models remain complementary approaches.

17 Sep 2026

CGM reveals glucose patterns linked to cardiometabolic risk in adults without diabetes

Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are the clinical gold standards for screening for blood sugar levels yet they provide only static snapshots that fail to reflect the highly dynamic and heterogeneous nature of metabolic impairment.

17 Sep 2026